<DOC>
	<DOCNO>NCT00070525</DOCNO>
	<brief_summary>This phase II trial study well tipifarnib work treat young patient recurrent progressive high-grade glioma , medulloblastoma , primitive neuroectodermal tumor , brain stem glioma . Tipifarnib may stop growth tumor cell block enzymes necessary growth .</brief_summary>
	<brief_title>Tipifarnib Treating Young Patients With Recurrent Progressive High-Grade Glioma , Medulloblastoma , Primitive Neuroectodermal Tumor , Brain Stem Glioma</brief_title>
	<detailed_description>OBJECTIVES : I . Determine response rate pediatric patient recurrent progressive high-grade glioma , medulloblastoma/primitive neuroectodermal tumor ( PNET ) , brain stem glioma treat tipifarnib . II . Determine distribution time progression , time treatment failure , time death patient treat drug . OUTLINE : This open-label , multicenter study . Patients stratify accord disease ( high-grade glioma v recurrent progressive medulloblastoma/primitive neuroectodermal tumor [ PNET ] v progressive diffuse , intrinsic brain stem glioma ) . Patients receive oral tipifarnib twice daily day 1-21 . Courses repeat every 28 day 2 year absence disease progression unacceptable toxicity .</detailed_description>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Astrocytoma</mesh_term>
	<mesh_term>Neuroectodermal Tumors</mesh_term>
	<mesh_term>Neuroectodermal Tumors , Primitive</mesh_term>
	<mesh_term>Medulloblastoma</mesh_term>
	<mesh_term>Oligodendroglioma</mesh_term>
	<mesh_term>Optic Nerve Glioma</mesh_term>
	<mesh_term>Tipifarnib</mesh_term>
	<criteria>Histologically confirm brain tumor , include follow : Anaplastic astrocytoma Glioblastoma multiforme Gliosarcoma Anaplastic oligodendroglioma Medulloblastoma/primitive neuroectodermal tumor ( PNET ) Diffuse intrinsic brain stem glioma* Progressive relapse disease prior conventional therapy Radiographic evidence measurable disease Performance status Karnofsky 60100 % ( 16 year age ) Performance status Lansky 60100 % ( 16 year age ) Performance status ECOG 02 At least 8 week Absolute neutrophil count least 1,000/mm^3 Platelet count least 100,000/mm^3 ( transfusion independent ) Hemoglobin least 8.0 g/dL ( red blood cell transfusion allow ) Bilirubin great 1.5 time upper limit normal ( ULN ) SGPT SGOT less 2.5 time ULN Creatinine clearance OR radioisotope glomerular filtration rate least 70 mL/min Maximum creatinine base age follow : 0.8 mg/dL ( 5 year ) 1.0 mg/dL ( 6 10 year ) 1.2 mg/dL ( 11 15 year ) 1.5 mg/dL ( 15 year ) Shortening fraction least 27 % echocardiogram Ejection fraction least 50 % MUGA No dyspnea rest No exercise intolerance Pulse oximetry great 94 % * Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception Seizure disorder allow provide wellcontrolled nonenzymeinducing anticonvulsant No active graftversushost disease No uncontrolled infection No allergy azoles ( e.g. , ketoconazole , itraconazole , fluconazole ) Recovered prior immunotherapy At least 7 day since prior antineoplastic biologic agent At least 1 month since prior autologous stem cell transplantation ( SCT ) At least 6 month since prior allogeneic SCT More 1 week since prior growth factor No concurrent immunomodulating agent More 2 week since prior myelosuppressive chemotherapy ( 46 week nitrosoureas temozolomide ) recover No concurrent anticancer chemotherapy Concurrent dexamethasone allow provided patient stable decrease dose least 1 week prior study entry Concurrent corticosteroid allow treatment increase intracranial pressure Recovered prior radiotherapy At least 2 week since prior local palliative radiotherapy ( small port ) At least 3 month since prior craniospinal radiotherapy At least 6 week since prior substantial bone marrow radiotherapy No concurrent palliative radiotherapy No prior initiation therapy another phase II study No concurrent participation another therapeutic COG study No concurrent enzymeinducing anticonvulsant No concurrent anticancer experimental drug No concurrent food medication interfere CYP3A4 , include follow : Carbamazepine Phenytoin Phenobarbital Grapefruit juice Erythromycin Azithromycin Clarithromycin Rifampin analogues Fluconazole Ketoconazole Itraconazole Cimetidine Cannabinoids ( i.e. , marijuana dronabinol ) Omeprazole Hypericum perforatum ( St. John 's wort ) Ethosuximide Glucocorticoids Griseofulvin Nafcillin Nelfinavir Norfloxacin Norfluoxetine Nevirapine Oxcarbazepine Phenylbutazone Primidone Progesterone ( progestin ) Rifabutin Rofecoxib Sulfadimidine Sulfinpyrazone Troglitazone Rifapentine Modafinil Amiodarone Anastrozole Clotrimazole Cyclosporine Danazol Delavirdine Diethyldithiocarbamate Diltiazem Dirithromycin Disulfiram Entacapone ( high dose ) Ethinyl estradiol Fluoxetine Fluvoxamine Gestodene Indinavir Isoniazid Metronidazole Mibefradil Miconazole Nefazodone Oxiconazole Paroxetine Propoxyphene Roxithromycin Quinidine Quinine Quinupristin dalfopristin Ranitidine Ritonavir Saquinavir Sertindole Sertraline Troleandomycin Valproic acid Verapamil Voriconazole Zafirlukast Zileuton</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>